Artículo de Revisión Referencias 1.- Berger Z. Pancreatitis autoinmune: sospecha, diagnóstico diferencial y manejo. Gastroenterol latinoam 2013; 24 Supp 1: S107-S11. 2.- Stone J, Zen Y, Deshpande V. IgG4- related disease. N Engl J Med 2012; 366: 539-51. 3.- Cai O, Tan S. From pathogenesis, clinical manifestation, and diagnosis to treatment: an overview on autoimmune pancreatitis. Gastroenterol Res Pract 2017; 2017: 3246459. Publicación electrónica en avance Ene 19. 4.- Lang D, Zwerina J, Pieringer H: IgG4- related disease: current challenges and future prospects. Ther Clin Risk Manag 2016; 12: 189-99. 5.- Frulloni L, Lunardi C, Simone R, Dolcino M, Scattolini C, Falconi M, et al. Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med 2009; 361: 2135-42. S 24 6.- Kawa S, Ota M, Yoshizawa K, Horiuchi A, Hamano H, Ochi Y, et al. HLA DRB1*0405-DQB1*0401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology 2002; 122: 1264-9. 7.- Chang MC, Jan IS, Liang PC, Jeng YM, Yang CY, Tien YW, et al. Cystic fibrosis transmembrane conductance regulator gene variants are associated with autoimmune pancreatitis and slow response to steroid treatment. J Cyst Fibros 2015; 14: 661-7. 8.- Ikeura1 T, Manfredi R, Zamboni G, Negrelli R, Capelli P, Amodio A, et al. Application of international consensus diagnostic criteria to an Italian series of autoimmune pancreatitis. United European Gastroenterol J 2013; 1: 276-84. 9.- Kerdsirichairat T, Saini SD, Chamberlain PR, Prabhu A. Autoimmune pancreatitis Pancreatitis autoi nmu ne - Z. Berger F. et al. diagnosed with core biopsy obtained from a novel fork-tip EUS needle. ACG Case Rep J 2017; 4: e7. 10.- Berger Z. Un desafío clínico: diagnóstico diferencial de pancreatitis autoinmune y cáncer de páncreas. El valor de tratamiento esteroidal de prueba. Rev Med Chile 2014; 142: 413-7. 11.- Okazaki K, Chari ST, Frulloni L, Lerch MM, Kamisawa T, Kawa S, et al. International consensus for the treatment of autoimmune pancreatitis. Pancreatology 2017; 17: 1-6. 12.- Hart PA, Topazian MD, Witzig TE, Clain JE, Gleeson FC, Klebig RR, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut 2013; 62: 1607-15. 13.- Berger Z, Mancilla C. Is autoimmune pancreatitis a subclass of chronic pancreatitis? Pancreatology 2017; 17: 55. Gastroenterol. latinoam 2017; V ol 28, Supl N º 1: S 21- S 24
gastrolat 2 2017
To see the actual publication please follow the link above